What does Apotheek Verbist do?

Apotheek Verbist is a logistics company in Zemst. Private Limited, started on 13 June 1986, 2 establishments.

What is the address of Apotheek Verbist?

The registered office of Apotheek Verbist is located at Brusselsesteenweg 390, 1980 Zemst.

Is Apotheek Verbist still active?

Yes. According to the CBE (30 October 2026) Apotheek Verbist is active, legal situation “Normale toestand”, started on 13 June 1986.

Is Apotheek Verbist registered on Peppol?

Yes, Apotheek Verbist is registered on the Peppol network with ID 0208:0429005363.

What is the enterprise number of Apotheek Verbist?

The enterprise number of Apotheek Verbist is BE0429005363.

When was Apotheek Verbist founded?

Apotheek Verbist was founded on 13 June 1986.

Who are the directors of Apotheek Verbist?

According to the 2025 annual accounts, the directors of Apotheek Verbist are: Stefaan Peeters, Koen Peeters, Lieve Victor.

Is Apotheek Verbist a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 June 1986; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account; 2 establishments in the CBE.

How much profit did Apotheek Verbist make in 2025?

Apotheek Verbist posted a profit after taxes of € 295,489 in financial year 2025.

What is the revenue of Apotheek Verbist?

As a small company, Apotheek Verbist is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 583,158.

How much does an employee at Apotheek Verbist earn?

The average wage cost per full-time employee at Apotheek Verbist was € 88,600 in 2024: staff costs of € 115,212 for 1.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Verbist have?

According to the 2025 annual accounts, Apotheek Verbist has 0.7 full-time equivalents (FTE).

Apotheek Verbist (Private Limited) - Zemst - BE0429005363

Dossier Apotheek Verbist, printed on 30 October 2026 from databakkes.be/en/0429005363/apotheek-verbist. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 2.8 to 0.7.

Financials

Financial year 2025

Apotheek Verbist from Zemst, company number BE0429005363, closed financial year 2025 with a result of € 295,489 after tax. For that financial year Apotheek Verbist recorded a gross margin of € 583,158 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 268,165 to € 295,489. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Healthy

€ 1.1 million

▼ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 295,489

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 390,942

▲ 115% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 435,990 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0.7

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 77,444

▼ 33% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,439

▼ 61% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 475,303

▼ 16% vs 2024

€ 93,563 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 133,349

▲ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 87,029

▼ 7% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 691,823 Gross margin 2022: € 691,823 First fiscal year in the series	€ 586,947 Gross margin 2023: € 586,947 ▼ 15% vs 2022 (€ 691,823) Unfavourable step	€ 630,821 Gross margin 2024: € 630,821 ▲ 7% vs 2023 (€ 586,947) Favourable step	€ 583,158 Gross margin 2025: € 583,158 ▼ 8% vs 2024 (€ 630,821) Unfavourable step	▼ 8%
Profit after taxes	€ 269,438 Profit after taxes 2022: € 269,438 First fiscal year in the series	€ 191,947 Profit after taxes 2023: € 191,947 ▼ 29% vs 2022 (€ 269,438) Unfavourable step	€ 268,165 Profit after taxes 2024: € 268,165 ▲ 40% vs 2023 (€ 191,947) Favourable step	€ 295,489 Profit after taxes 2025: € 295,489 ▲ 10% vs 2024 (€ 268,165) Favourable step	▲ 10%
Equity	€ 881,959 Equity 2022: € 881,959 First fiscal year in the series	€ 1,039,685 Equity 2023: € 1,039,685 ▲ 18% vs 2022 (€ 881,959) Favourable step	€ 1,254,610 Equity 2024: € 1,254,610 ▲ 21% vs 2023 (€ 1,039,685) Favourable step	€ 1,114,108 Equity 2025: € 1,114,108 ▼ 11% vs 2024 (€ 1,254,610) Unfavourable step	▼ 11%
Total debts	€ 1,074,160 Total debts 2022: € 1,074,160 First fiscal year in the series	€ 834,536 Total debts 2023: € 834,536 ▼ 22% vs 2022 (€ 1,074,160) Favourable step	€ 912,764 Total debts 2024: € 912,764 ▲ 9% vs 2023 (€ 834,536) Unfavourable step	€ 1,032,732 Total debts 2025: € 1,032,732 ▲ 13% vs 2024 (€ 912,764) Unfavourable step	▲ 13%
Cash	€ 313,398 Cash 2022: € 313,398 First fiscal year in the series	€ 174,112 Cash 2023: € 174,112 ▼ 44% vs 2022 (€ 313,398) Unfavourable step	€ 181,996 Cash 2024: € 181,996 ▲ 5% vs 2023 (€ 174,112) Favourable step	€ 390,942 Cash 2025: € 390,942 ▲ 115% vs 2024 (€ 181,996) Favourable step	▲ 115%
Land & buildings	€ 715,189 Land & buildings 2022: € 715,189 First fiscal year in the series	€ 668,460 Land & buildings 2023: € 668,460 ▼ 7% vs 2022 (€ 715,189) Unchanged	€ 956,601 Land & buildings 2024: € 956,601 ▲ 43% vs 2023 (€ 668,460) Unchanged	€ 909,872 Land & buildings 2025: € 909,872 ▼ 5% vs 2024 (€ 956,601) Unchanged	▼ 5%
Retained profit	€ 863,409 Retained profit 2022: € 863,409 First fiscal year in the series	€ 1,021,135 Retained profit 2023: € 1,021,135 ▲ 18% vs 2022 (€ 863,409) Favourable step	€ 1,236,060 Retained profit 2024: € 1,236,060 ▲ 21% vs 2023 (€ 1,021,135) Favourable step	€ 1,095,558 Retained profit 2025: € 1,095,558 ▼ 11% vs 2024 (€ 1,236,060) Unfavourable step	▼ 11%
Dividend	€ 114,764 Dividend 2022: € 114,764 First fiscal year in the series	€ 34,221 Dividend 2023: € 34,221 ▼ 70% vs 2022 (€ 114,764) Unchanged	€ 53,240 Dividend 2024: € 53,240 ▲ 56% vs 2023 (€ 34,221) Unchanged	€ 435,990 Dividend 2025: € 435,990 ▲ € 382,750 vs 2024 (€ 53,240) Unchanged	▲ € 382,750
Bank debt	€ 763,327 Bank debt 2022: € 763,327 First fiscal year in the series	€ 655,753 Bank debt 2023: € 655,753 ▼ 14% vs 2022 (€ 763,327) Favourable step	€ 566,618 Bank debt 2024: € 566,618 ▼ 14% vs 2023 (€ 655,753) Favourable step	€ 475,303 Bank debt 2025: € 475,303 ▼ 16% vs 2024 (€ 566,618) Favourable step	▼ 16%
Balance sheet total	€ 1,956,119 Balance sheet total 2022: € 1,956,119 First fiscal year in the series	€ 1,874,221 Balance sheet total 2023: € 1,874,221 ▼ 4% vs 2022 (€ 1,956,119) Unchanged	€ 2,167,374 Balance sheet total 2024: € 2,167,374 ▲ 16% vs 2023 (€ 1,874,221) Unchanged	€ 2,146,841 Balance sheet total 2025: € 2,146,841 ▼ 1% vs 2024 (€ 2,167,374) Unchanged	▼ 1%
Employees (FTE)	3.3 Employees (FTE) 2022: 3.3 First fiscal year in the series	2.8 Employees (FTE) 2023: 2.8 ▼ 0.5 vs 2022 (3.3) Unchanged	1.3 Employees (FTE) 2024: 1.3 ▼ 1.5 vs 2023 (2.8) Unchanged	0.7 Employees (FTE) 2025: 0.7 ▼ 0.6 vs 2024 (1.3) Unchanged	▼ 0.6

Key figures of Apotheek Verbist, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Verbist?

What happened at Apotheek Verbist in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 295,489 (▲ 10% vs 2024). Source: NBB ↗
2023 Koen Peeters became a director. NBB
2020 Stefaan Peeters became a director. NBB
2020 Lieve Victor became a director. NBB
Dec 14, 2007 New establishment in Zemst. KBO
May 26, 1987 New establishment in Zemst. KBO
Jun 13, 1986 Start of the company according to the CBE. KBO

In short

From € 269,438 profit in 2022 to € 295,489 profit in 2025.

Paid € 362,338 in corporate taxes since 2022.

Best year ever: 2025, with € 295,489 profit.

On average € 485,200 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

Stefaan Peeters Koen Peeters Lieve Victor

JODI

Apotheek Verbist

Pharma Universalis

Brabants Apothekers Forum

Behind Apotheek Verbist are Stefaan Peeters, Koen Peeters and Lieve Victor. Stefaan Peeters is also behind JODI. Koen Peeters is also behind Pharma Universalis. Lieve Victor is also behind Brabants Apothekers Forum, OZOS - Optimale Zorg door Optimale Samenwerking, JODI, Easytocare and LOKAAL GEZONDHEIDSOVERLEG Zenneland.

Directors

According to the 2025 annual accounts

Stefaan Peeters

Director

Also active at: JODI

since 2020

Koen Peeters

Director

Also active at: Pharma Universalis

since 2023

Lieve Victor

Director

Also active at: Brabants Apothekers Forum, OZOS - Optimale Zorg door Optimale Samenwerking, JODI, Easytocare, LOKAAL GEZONDHEIDSOVERLEG Zenneland, Eerstelijnszone BraViO (Brabant, Vilvoorde en Omgeving)

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Brusselsesteenweg 390

1980 Zemst

2.281.018.148

Dorpsstraat 46

1982 Zemst

Active since 14 December 2007

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0429.005.363

VAT number

BE 0429.005.363

Registered office

Brusselsesteenweg 390, 1980 Zemst

Names & denominations

Apotheek Verbist

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 June 1986

Peppol

Active · Active since 24 Nov 2023

Contact

[email protected] 015612187

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Verbist

Warning lights

Financials

What happened to Apotheek Verbist?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions